Global Competent Cells Market Analysis, Trends, and Forecasts 2019-2025 - ResearchAndMarkets.com

DUBLIN--()--The "Competent Cells - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Competent Cells market worldwide is projected to grow by US$1.5 Million, guided by a compounded growth of 10.3%.

Staying on top of trends is essential for decision makers to leverage this emerging opportunity. The report addresses this very need and provides the latest scoop on all major market segments. Chemically Competent Cells, one of the segments analyzed and sized in this study, displays the potential to grow at over 10%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$2 Million by the year 2025, Chemically Competent Cells will bring in healthy gains adding significant momentum to global growth.

While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 12.6% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$115.5 Thousand to the region's size and clout in the next 5 to 6 years. Over US$145.2 Thousand worth of projected demand in the region will come from other emerging Eastern European markets.

In Japan, Chemically Competent Cells will reach a market size of US$139.1 Thousand by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9.7% over the next couple of years and add approximately US$247.2 Thousand in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Genscript Biotech Corporation
  • Illumina
  • Merck Kgaa
  • New England Biolabs
  • Origene Technologies
  • Promega Corporation
  • Qiagen Nv
  • Takara Bio
  • Thermo Fisher Scientific
  • Zymo Research Corporation

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Competent Cells Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Global Competitor Market Shares by Segment
  • Electrocompetent Cells (Type) Global Competitor Market Share Positioning for 2019 & 2025
  • Chemically Competent Cells (Type) Market Share Breakdown of Key Players: 2019 & 2025
  • Clean-Label Starch Innovations
  • Chemically Competent Cells Segment Dominate in North America
  • Drivers & Restrains Summarized for Competent Cells Market
  • Cloning is Expected to Take the Largest Share of Competent Cells Market
  • Competent Cells Growth Outlook
  • Competent Cells Application Trends
  • Academic and Research Institutes Emerge as Largest End Users of Competent Cells Market
  • Leading Players in competent cells market

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Advancements in Molecular Cloning Drives Competent Cell Market
  • SGI-DNA Inc has Launched Vmax Express Chemically Competent Cells .
  • Increasing Research on Cloning Demands Competent Cells Requirement
  • Increasing Intensity of Research and Technological Advancements Drives Market
  • Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022
  • As the Foundation for Modern Biomolecular Research, Importance of Recombinant Proteins Spurs Demand for Competent Cells
  • Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022
  • As Molecular Engineering Takes Huge Strides Forward in Manipulating & Harnessing the DNA for the Production of More Potent Therapies, Poised to Benefit are Ready-to-Use Competent Cells
  • Escherichia coli, the Most Widely Used Organism in the Expression of Cloned Proteins
  • Need for DNA Library Construction in Molecular Cloning Benefits Demand for Competent Cells
  • Need for Faster Characterization Proteins & More Efficient Protein Expression Spurs the Use of Competent Cells
  • Rise of Protein Expression Services Offering Flexible, Low-Cost Production of High-Quality, Bioactive Recombinant Proteins, Bodes Well for Market Growth
  • Higher Transformation Efficiencies Give Electroporation an Edge Over Chemical Methods
  • Heat Shock Treatment for Transformation of Competent Cells, Another Popular Method
  • Increased Investments in Life Sciences Research to Expand the Addressable Market Opportunity for Competent Cells
  • Rising Global Pharmaceutical R&D Offers a Fertile Environment for the Growth in Demand for Competent Cells: Global Pharmaceutical R&D (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
  • Continuous Developments in Chemical Transformation Technologies to Benefit Market Growth
  • Rise in Non-Communicable Diseases, a Key Macro Trend Shaping Demand for Recombinant Enzymes & Proteins in Drug Discovery
  • Mind Bending Economic Burden of Noncommunicable Diseases (NCDs) Drives Urgent Investments in Drug Research & Development, Opening Up Opportunities for Competent Cells in Mass Production of Therapeutic Proteins: Cumulative Global Burden of NCDs (In US$ Trillion) for the Period 2011-2030
  • Cell Free Protein Expression & the Accompanying Promise of the Development of a Versatile Mass Production System for Protein Expression to Benefit Market Growth

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

  • Market Facts & Figures
  • US Competent Cells Market Share (in %) by Company: 2019 & 2025
  • Electrocompetent Cells (Type) Market Share Analysis (in %) of Leading Players in the US for 2019 & 2025
  • Chemically Competent Cells (Type) Competitor Revenue Share (in %) in the US: 2019 & 2025

CANADA

JAPAN

CHINA

EUROPE

  • Market Facts & Figures
  • European Competent Cells Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • Electrocompetent Cells (Type) Market Share (in %) by Company in Europe: 2019 & 2025
  • Chemically Competent Cells (Type) Market Share (in %) of Major Players in Europe: 2019 & 2025

FRANCE

GERMANY

ITALY

UNITED KINGDOM

REST OF EUROPE

ASIA-PACIFIC

REST OF WORLD

IV. COMPETITION

  • Agilent Technologies
  • Bio-Rad Laboratories
  • Genscript Biotech Corporation
  • Illumina
  • Merck Kgaa
  • New England Biolabs
  • Origene Technologies
  • Promega Corporation
  • Qiagen Nv
  • Takara Bio
  • Thermo Fisher Scientific
  • Zymo Research Corporation

V. CURATED RESEARCH

For more information about this report visit https://www.researchandmarkets.com/r/v8aaxu

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900